WB, IP, IF-F, IF-IC
H M R
Endogenous
68, 70
Rabbit IgG
#Q13492
8301
Product Information
Product Usage Information
| Application | Dilution |
|---|---|
| Western Blotting | 1:1000 |
| Immunoprecipitation | 1:50 |
| Immunofluorescence (Frozen) | 1:200 - 1:800 |
| Immunofluorescence (Immunocytochemistry) | 1:800 - 1:3200 |
Storage
Specificity / Sensitivity
Species Reactivity:
Human, Mouse, Rat
Source / Purification
Monoclonal antibody is produced by immunizing animals with recombinant protein specific to the carboxy terminus of human PICALM protein.
Background
Phosphatidylinositol-binding clathrin assembly protein (PICALM) is a clathrin-binding cytosolic protein. Clathrin is a triskelion-shaped protein that plays a major role in the formation of coated vesicles (1). Formation of these vesicles is critical for shaping the cell membrane to promote intracellular trafficking for multiple membrane trafficking pathways in the cell, including the trans-Golgi network as well as transport to and from the cell membrane and endosomal compartments. Several clathrin adaptor proteins regulate assembly and recruitment to the membrane, including AP2, EPS-15, and Epsin. PICALM, also known as clathrin assembly lymphoid myeloid leukemia protein (CALM), was identified based on genetic homology to clathrin assembly synaptic protein AP180, which as the name suggests, is also a clathrin-associated adaptor protein, particularly in the brain (2). PICALM, along with AP2 and clathrin, are one of the most abundant components of clathrin-coated vesicles, which consists of clathrin triskelia, adaptors, and other accessory proteins at specific plasma membrane sites which function to initiate vesicular budding from the membrane (3). PICALM is a single peptide chain that contains an N-terminal AP180-amino-terminal-homology (ANTH) domain, which mediates binding to phosphoinositides on the plasma membrane. The C-terminal domain of PICALM contains binding motifs for clathrin, AP2, and EPS15 (4). Interestingly, the gene that encodes PICALM has been genetically linked to neurodegenerative diseases, and alterations of PICALM’s role in clathrin-mediated endocytosis may contribute to cellular mechanisms of amyloid β pathology as well as tau accumulation and transmission (5-7).
- Kaksonen, M. and Roux, A. (2018) Nat Rev Mol Cell Biol 19, 313-326.
- Dreyling, M.H. et al. (1996) Proc Natl Acad Sci U S A 93, 4804-9.
- Borner, G.H. et al. (2012) J Cell Biol 197, 141-60.
- Willy, N.M. et al. (2021) Proc Natl Acad Sci U S A 118, e2010438118. doi: 10.1073/pnas.2010438118.
- Hattersley, K.J. et al. (2021) Biochem Biophys Res Commun 570, 103-109.
- Ando, K. et al. (2020) Acta Neuropathol 139, 773-789.
- Harold, D. et al. (2009) Nat Genet 41, 1088-93.
Species Reactivity
Species reactivity is determined by testing in at least one approved application (e.g., western blot).
Western Blot Buffer
IMPORTANT: For western blots, incubate membrane with diluted primary antibody in 5% w/v nonfat dry milk, 1X TBS, 0.1% Tween® 20 at 4°C with gentle shaking, overnight.
Applications Key
WB: Western Blotting IP: Immunoprecipitation IF-F: Immunofluorescence (Frozen) IF-IC: Immunofluorescence (Immunocytochemistry)
Cross-Reactivity Key
H: human M: mouse R: rat Hm: hamster Mk: monkey Vir: virus Mi: mink C: chicken Dm: D. melanogaster X: Xenopus Z: zebrafish B: bovine Dg: dog Pg: pig Sc: S. cerevisiae Ce: C. elegans Hr: horse GP: Guinea Pig Rab: rabbit All: all species expected
Trademarks and Patents
Limited Uses
Except as otherwise expressly agreed in a writing signed by a legally authorized representative of CST, the following terms apply to Products provided by CST, its affiliates or its distributors. Any Customer's terms and conditions that are in addition to, or different from, those contained herein, unless separately accepted in writing by a legally authorized representative of CST, are rejected and are of no force or effect.
Products are labeled with For Research Use Only or a similar labeling statement and have not been approved, cleared, or licensed by the FDA or other regulatory foreign or domestic entity, for any purpose. Customer shall not use any Product for any diagnostic or therapeutic purpose, or otherwise in any manner that conflicts with its labeling statement. Products sold or licensed by CST are provided for Customer as the end-user and solely for research and development uses. Any use of Product for diagnostic, prophylactic or therapeutic purposes, or any purchase of Product for resale (alone or as a component) or other commercial purpose, requires a separate license from CST. Customer shall (a) not sell, license, loan, donate or otherwise transfer or make available any Product to any third party, whether alone or in combination with other materials, or use the Products to manufacture any commercial products, (b) not copy, modify, reverse engineer, decompile, disassemble or otherwise attempt to discover the underlying structure or technology of the Products, or use the Products for the purpose of developing any products or services that would compete with CST products or services, (c) not alter or remove from the Products any trademarks, trade names, logos, patent or copyright notices or markings, (d) use the Products solely in accordance with CST Product Terms of Sale and any applicable documentation, and (e) comply with any license, terms of service or similar agreement with respect to any third party products or services used by Customer in connection with the Products.